These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 16556865)

  • 1. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.
    Shamgar L; Ma L; Schmitt N; Haitin Y; Peretz A; Wiener R; Hirsch J; Pongs O; Attali B
    Circ Res; 2006 Apr; 98(8):1055-63. PubMed ID: 16556865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional effects of a KCNQ1 mutation associated with the long QT syndrome.
    Boulet IR; Raes AL; Ottschytsch N; Snyders DJ
    Cardiovasc Res; 2006 Jun; 70(3):466-74. PubMed ID: 16564513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
    Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
    Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
    Aromolaran AS; Subramanyam P; Chang DD; Kobertz WR; Colecraft HM
    Cardiovasc Res; 2014 Dec; 104(3):501-11. PubMed ID: 25344363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
    Ohno S; Toyoda F; Zankov DP; Yoshida H; Makiyama T; Tsuji K; Honda T; Obayashi K; Ueyama H; Shimizu W; Miyamoto Y; Kamakura S; Matsuura H; Kita T; Horie M
    Hum Mutat; 2009 Apr; 30(4):557-63. PubMed ID: 19306396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic probucol treatment decreases the slow component of the delayed-rectifier potassium current in CHO cells transfected with KCNQ1 and KCNE1: a novel mechanism of QT prolongation.
    Taniguchi T; Uesugi M; Arai T; Yoshinaga T; Miyamoto N; Sawada K
    J Cardiovasc Pharmacol; 2012 Apr; 59(4):377-86. PubMed ID: 22189896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
    El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
    J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oxidant thimerosal modulates gating behavior of KCNQ1 by interaction with the channel outer shell.
    Kerst G; Brousos H; Schreiber R; Nitschke R; Hug MJ; Greger R; Bleich M
    J Membr Biol; 2002 Mar; 186(2):89-100. PubMed ID: 11944086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of functional properties of KCNQ1 channel by association of KCNE1 and KCNE2.
    Toyoda F; Ueyama H; Ding WG; Matsuura H
    Biochem Biophys Res Commun; 2006 Jun; 344(3):814-20. PubMed ID: 16631607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
    Jow F; Tseng E; Maddox T; Shen R; Kowal D; Dunlop J; Mekonnen B; Wang K
    Assay Drug Dev Technol; 2006 Aug; 4(4):443-50. PubMed ID: 16945016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A590T mutation in KCNQ1 C-terminal helix D decreases IKs channel trafficking and function but not Yotiao interaction.
    Kinoshita K; Komatsu T; Nishide K; Hata Y; Hisajima N; Takahashi H; Kimoto K; Aonuma K; Tsushima E; Tabata T; Yoshida T; Mori H; Nishida K; Yamaguchi Y; Ichida F; Fukurotani K; Inoue H; Nishida N
    J Mol Cell Cardiol; 2014 Jul; 72():273-80. PubMed ID: 24713462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular mechanism for adrenergic-induced long QT syndrome.
    Wu J; Naiki N; Ding WG; Ohno S; Kato K; Zang WJ; Delisle BP; Matsuura H; Horie M
    J Am Coll Cardiol; 2014 Mar; 63(8):819-27. PubMed ID: 24184248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
    Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
    Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long QT mutations at the interface between KCNQ1 helix C and KCNE1 disrupt I(KS) regulation by PKA and PIP₂.
    Dvir M; Strulovich R; Sachyani D; Ben-Tal Cohen I; Haitin Y; Dessauer C; Pongs O; Kass R; Hirsch JA; Attali B
    J Cell Sci; 2014 Sep; 127(Pt 18):3943-55. PubMed ID: 25037568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
    Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
    Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic partnership between KCNQ1 and KCNE1 and influence on cardiac IKs current amplitude by KCNE2.
    Jiang M; Xu X; Wang Y; Toyoda F; Liu XS; Zhang M; Robinson RB; Tseng GN
    J Biol Chem; 2009 Jun; 284(24):16452-16462. PubMed ID: 19372218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition of calcified calmodulin N lobe and PIP2 to an LQT mutation site in Kv7.1 channel.
    Tobelaim WS; Dvir M; Lebel G; Cui M; Buki T; Peretz A; Marom M; Haitin Y; Logothetis DE; Hirsch JA; Attali B
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E869-E878. PubMed ID: 28096388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome.
    Hoosien M; Ahearn ME; Myerburg RJ; Pham TV; Miller TE; Smets MJ; Baumbach-Reardon L; Young ML; Farooq A; Bishopric NH
    Heart Rhythm; 2013 May; 10(5):728-37. PubMed ID: 23291057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the IKs channel complex inhibits drug block: novel mechanism underlying variable antiarrhythmic drug actions.
    Yang T; Kanki H; Roden DM
    Circulation; 2003 Jul; 108(2):132-4. PubMed ID: 12835205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoproterenol exacerbates a long QT phenotype in Kcnq1-deficient neonatal mice: possible roles for human-like Kcnq1 isoform 1 and slow delayed rectifier K+ current.
    Knollmann BC; Casimiro MC; Katchman AN; Sirenko SG; Schober T; Rong Q; Pfeifer K; Ebert SN
    J Pharmacol Exp Ther; 2004 Jul; 310(1):311-8. PubMed ID: 15004216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.